Description / Scope​ of the Technical Need.

We are looking for breakthrough, clinically proven consumer healthcare solutions for the prevention, self-diagnosis, and treatment of allergic conditions. This includes innovative formats, drug delivery systems, APIs, devices, and consumer services/experiences.​

Background.

Opella is a leading innovator in effective allergy relief solutions, empowering consumers to take health in their hands.​

As a market leader in self-care, we are dedicated to continuous investment in cutting-edge research and strategic collaborations. Our mission is to develop advanced, safe, and accessible allergy relief products that enhance daily comfort and improve the quality of life for our consumers.​

Key Success Criteria.

Must-have Requirements.

  • A strong differentiation versus existing solutions with a distinct benefit or unmet consumer need that is clearly communicable​
  • Proposals should be supported by robust science (evidence of efficacy & safety) and early-stage developments should have a proof-of-concept​
  • Any technology or device used must have sound scientific rationale and a viable prototype​

 

Preferred Requirements. ​

  • Cost plays a major role in the over-the-counter space and often is a limiting factor; solutions need to be in an acceptable cost range for the consumer​
  • Proposed path to market recommendations​

 

Approaches​ not of interest.

  • Out of scope are solutions that:​
  • Fall outside the Over-the-counter (OTC) setting and require doctor's supervision/support​
  • Are not sustainable and do not meet our product quality standards​
  • Have only benefits that cannot be clearly communicated to consumers in an OTC environment​
  • Contain oral probiotics without clinical data to support a clear allergy claim​

 

Target Group​.

Adults and children, no specific health conditions​

 

Geographies​.

Global

Submit solution.

Reach 
out.

Have a question or simply want to know more?

Drop us a line.

Any question or adverse reaction related to our products must be addressed via www.sanofi.com.